A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CLSI / Clinical and Laboratory Standards Institute

[Related PubMed/MEDLINE]
Total Number of Papers: 1165
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CLSI  (>> Co-occurring Abbreviation)
Long Form:   Clinical and Laboratory Standards Institute
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators. CAP, CFRs, EUCAST, MICs, PK, PK/PD, PTA
2019 Accuracy of blood glucose measurements using the NOVA StatStrip glucometer during cardiac surgery: a prospective observational study. CPB, POCT
2019 Antibiotic resistance in Bangladesh: A systematic review. ABR, ESBL, IQR, MR, MRSA
2019 Antimicrobial resistance of staphylococcus aureus causing of surgical site infections in ear, nose and throat surgery. ENT, SSI
2019 Antioxidant, Gastroprotective, Cytotoxic Activities and UHPLC PDA-Q Orbitrap Mass Spectrometry Identification of Metabolites in Baccharis grisebachii Decoction. ---
2019 Association between herd management practices and antimicrobial resistance in Salmonella spp. from cull dairy cattle in Central California. AMR, CI, MDR
2019 Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016. CARST, ESBLs, EUCAST, MICs, MRSA, MRSE, VRE
2019 Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping. IVD, MALDI-TOF MS, MLST, PFGE, RUO
2019 Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS. AFST, FLU
10  2019 Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period. IC, MICs
11  2019 Changing paradigm of antibiotic resistance amongst Escherichia coli isolates in Indian pediatric population. QRDR, SNP
12  2019 Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. GNB, MDR, MRSA, UTI, VRE, XDR
13  2019 Commutability of external quality assessment materials for serum sodium and potassium measurements. EQA, ETVs, GCs
14  2019 Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens. MICs
15  2019 Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa. PK/PD
16  2019 Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China. ESBLs
17  2019 Establishing a blood fructosamine reference range for the Brazilian population based on data from ELSA - Brasil. ---
18  2019 Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019 Enterobacteriaceae CLSI Breakpoints. CA, ME, mE, VME
19  2019 Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital. ---
20  2019 Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex. CF
21  2019 Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016. MDR
22  2019 Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility. AST, ME, MICs, NPV, NTM, PPV, VME
23  2019 In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015. ESBLs, INFORM, MBL, MDR
24  2019 In vitro activity of dihydrofolate reductase inhibitors and other antibiotics against Gram-positive pathogens collected globally between 2004 and 2016. MICs
25  2019 In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study. ESBL, MDR
26  2019 In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex. ---
27  2019 Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis. C. albicans, FICIs
28  2019 Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, Center of Iran. FLU, ITC, TER
29  2019 Molecular characterization of class 1, 2 and 3 integrons in clinical multi-drug resistant Klebsiella pneumoniae isolates. CS
30  2019 Normal Reference Intervals of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: a Large Multi-Center Study from Western China. LMR, NLR, PLR, RIs, SII
31  2019 Plasmid-Mediated Quinolone Resistance in Pseudomonas aeruginosa Isolated from Burn Patients in Tehran, Iran. rep-PCR
32  2019 Rapid liquid chromatography-tandem mass spectrometry to determine very-long-chain fatty acids in human and to establish reference intervals for the Chinese population. CVs, VLCFAs
33  2019 Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin. AST, AZI, CRO, ECV, EUCAST, IM, MIC, US
34  2019 Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and children. Abs, CLIA, T1DM
35  2019 Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth. ID-CAMHB
36  2019 Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints. MIC
37  2019 Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus. AUC, ESBL, MICs
38  2019 Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe. MIC
39  2019 Susceptibility breakpoint for Danofloxacin against swine Escherichia coli. E. coli, ECV, MICs, PK, WT
40  2019 Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents. PID
41  2019 Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria. mcr-1, MIC
42  2019 Uncertainty of measurement for 14 immunoassay analytes: application to laboratory result interpretation. NPAAC, RCV
43  2019 Understanding and Addressing CLSI Breakpoint Revisions - A Primer for Clinical Laboratories. ---
44  2019 User competency is still a major factor affecting analytical performance of glucose meters in patient service. POCT, QC
45  2019 Utility of broad-range 16S rRNA PCR assay versus conventional methods for laboratory diagnosis of bacterial endophthalmitis in a tertiary care hospital. rRNA
46  2019 [Central Aortic Pressure: Reference and Diagnostic Values]. BP, CAP
47  2018 Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii. FDA, MICs
48  2018 Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms. C/A, C/T, CRPA
49  2018 Activity of imipenem/relebactam against Pseudomonas aeruginosa with antimicrobial-resistant phenotypes from seven global regions: SMART 2015-2016. MDR, SMART
50  2018 Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study. AMR, ERIC-PCR, ESBL, HAI, ICU, ST131
51  2018 Analysis of chemical composition and in vitro antidermatophyte activity of ethanol extracts of Dryopteris fragrans (L.) Schott. FIC, MCZ, MFC, MIC, TBF, UPLC
52  2018 Analysis of Potential beta-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae. FDA
53  2018 Analytical evaluation of the ADAMS™ A1c HA8180T analyzer for the measurement of HbA1c. Hb
54  2018 Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms. MRSA
55  2018 Antibiotic resistance and molecular characterization of diarrheagenic Escherichia coli and non-typhoidal Salmonella strains isolated from infections in Southwest China. AMC, CEP, CIP, DEC, GEN, NTS, PFGE, SXT
56  2018 Antifungal Activity of Xylitol against Candida albicans: An in vitro Study. CFUs, MFC, MIC
57  2018 Antifungal effects of ethanolic and aqueous extracts of Vitexagnus-castus against vaginal isolates of Candida albicans. MICs, PCR-RFLP
58  2018 Antifungal Susceptibility of Candida Species Isolated from Horticulturists with Onychomycosis in Piaui, Brazil. ---
59  2018 Antimicrobial resistance in urine and skin isolates in Timor-Leste. AMR, CA-MRSA, ESBL
60  2018 Antimicrobial Resistance Pattern and Spectrum of Multiple-drug-resistant Enterobacteriaceae in Iranian Hospitalized Patients with Cancer. MDR, MEN
61  2018 Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran. ESBL, MBL, MDR
62  2018 Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates. EUCAST, MICs, ST
63  2018 Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogenscollected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial. ESBL, FDA, MIC, MRSA, PRSP, T.E.S.T, VR
64  2018 Antimicrobial susceptibility and clinical characteristics of Nocardia isolates from a tertiary care centre diagnostic laboratory in Pakistan. BMD
65  2018 Antimicrobial susceptibility of Flavobacterium psychrophilum isolates from the United Kingdom. BCWD, NRI, NWT, RTFS
66  2018 Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). ESBL, SMART
67  2018 Antimicrobial susceptibility pattern of aerobes in diabetic foot ulcers in a South-Indian tertiary care hospital. AMAs, AMS, DFIs, DFU, MDR
68  2018 Antimicrobial susceptibility survey on bacterial agents of canine and feline urinary tract infections: Weight of the empirical treatment. UTIs
69  2018 Antimicrobial Susceptibility Testing of Bacteria of Veterinary Origin. VAST
70  2018 Are In Vitro Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia? CBPs
71  2018 Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa. Ma, VM
72  2018 Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates. AST, EUCAST
73  2018 Assessment of the performance of blood glucose monitoring systems for monitoring dysglycaemia in neonatal patients. BGMS, NIST
74  2018 Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016. AGAR, EUCAST, GNSOP
75  2018 Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015. AGAR, EUCAST, GNSOP
76  2018 Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015. AGAR, ASSOP, EUCAST
77  2018 Bacteriological Study Among Influenza-like Illness Cases in a Community Setting in Pune, India. ARI, ILI
78  2018 beta-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China. BSAC, EUCAST, M. catarrhalis
79  2018 Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds. ---
80  2018 Burkholderia cepacia complex infections: More complex than the bacterium name suggest. Bcc, EUCAST
81  2018 Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing? CRE, LTAC, MIC, PCR
82  2018 Cephalexin susceptibility breakpoint for veterinary isolates: Clinical Laboratory Standards Institute revision. PTA
83  2018 Changes in resistance to and antimicrobial activity of antibiotics during in vitro human digestion. MRSA, SA RN4220
84  2018 Chemical characterization and antifungal activity of Origanum vulgare, Thymus vulgaris essential oils and carvacrol against Malassezia furfur. EOs, MICs
85  2018 Clinical and laboratory standards institute versus European committee for antimicrobial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI). AST, EUCAST, UTI, UTIs
86  2018 Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations. MIC, OR
87  2018 CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. ASTs, cASTs
88  2018 CLSI-based transference and verification of CALIPER pediatric reference intervals for 29 Ortho VITROS 5600 chemistry assays. CALIPER, RIs
89  2018 Commutability of control materials for external quality assessment of serum apolipoprotein A-I measurement. apoA-I, EQA, FSPs, PIs, RSPs
90  2018 Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. QC, RiliBAK, SD
91  2018 Comparison of Three Routine Methods for the Measurement of Serum Bilirubin in a China Laboratory. ---
92  2018 Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015). NIPP
93  2018 Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints. ESBL, MDR, MICs
94  2018 Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone. ABSSSI, FDA, MRSA
95  2018 Detection of plasmid-mediated quinolone resistance in clinical isolates of Enterobacteriaceae strains in Hamadan, West of Iran. PMQR
96  2018 Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach. 99th URL, AMI, CKD, eGFR, hs-cTnT
97  2018 Determination of Tedizolid susceptibility interpretive criteria for gram-positive pathogens according to clinical and laboratory standards institute guidelines. MIC
98  2018 Distribution of extended-spectrum beta-lactamases (ESBLs) among Salmonella serogroups isolated from pediatric patients. ESBLs
99  2018 Evaluation of a new hemoglobin A1c analyzer for point-of-care testing. HbA1c, POCT, ROC
100  2018 Evaluation of a newly developed chemiluminescence immunoassay for detecting cardiac troponin T. cTnT